RETRACTION: The Use of BT-ESD Technology under General Intravenous Anesthesia in the Treatment of Nonmuscle Invasive Bladder Cancer and the Effect of PI3K/Akt Signaling Pathway on Tumor Recurrence (Retraction of Vol 2021, art no 8860745, 2021)

被引：0

|

作者：

Yan, H.

Xia, S.

Yao, D.

Shi, J.

Liu, Z.

机构：

来源：

BIOMED RESEARCH INTERNATIONAL | 2024年 / 2024卷

关键词：

D O I：

10.1155/2024/9815062

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页数：1

相关论文

共 30 条

[21] RETRACTION: G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway (Retraction of Vol 140, art no 103129, 2020)
Qiao, Hai-Feng
Liu, Ying-Lei
You, Jun
Zheng, Yan-Li
Chen, Li-Ping
Lu, Xiao-Yan
Du, Lei
Shan, Feng
Liu, Man-Hua
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2022, 150
[22] RETRACTION: 0D/2D Coordination Complexes: Magnetic Studies, Protection, and Mechanism against Ischemic Myocardial Damage by Reducing the Activation of the PI3K/Akt Signaling Pathway (Retraction of Vol 6, Pg 5408, 2021)
Xue, Xiang
Shen, Yu-Lan
Cheng, Yang-Yang
Rong, Jingfeng
Zhou, Hua
Chi, Hao
ACS OMEGA, 2023, 8 (22): : 20151 - 20151
[23] RETRACTION: MiR-126 Regulates Proliferation and Invasion in the Bladder Cancer BLS Cell Line by Targeting the PIK3R2-Mediated PI3K/Akt Signaling Pathway (Retraction of Vol 9, Pg 5181, 2016)
Xiao, J.
Lin, H.
Zhu, Y.
Zhu, Y.
Chen, L.
ONCOTARGETS AND THERAPY, 2021, 14 : 1859 - 1859
[24] RETRACTION: Tim-4 promotes the growth of colorectal cancer by activating angiogenesis and recruiting tumor-associated macrophages via the PI3K/AKT/mTOR signaling pathway (Retraction of Vol 436, Pg 119, 2018)
Tan, Xiao
Zhang, Zhongqiang
Yao, Hongliang
Shen, Liangfang
CANCER LETTERS, 2023, 558
[25] RETRACTION: Long non-coding RNA HULC promotes bladder cancer cells proliferation but inhibits apoptosis via regulation of ZIC2 and PI3K/AKT signaling pathway (Retraction of Vol 20, Pg 425, 2017)
Wang, Jintao
Ma, Weimin
Liu, Yidong
CANCER BIOMARKERS, 2022, 35 (03) : 345 - 345
[26] RETRACTION: Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway (Retraction of Vol 36, Pg 581, 2020)
不详
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2024, 40 (10): : 954 - 954
[27] RETRACTION: Circ_0017639 facilitates proliferative, migratory, and invasive potential of non-small cell lung cancer (NSCLC) cells via PI3K/AKT signaling pathway (vol 13, pg 1590, 2022) (Retraction of Vol 13, Pg 1590, 2022)
Zhang, Hong-Bo
Qiu, Xiang-Ming
Zhang, Yi-Chao
Huang, Ting-Ting
Zuo, Zhan-Jie
Zhang, Tao
BIOENGINEERED, 2024, 15 (01)
[28] RETRACTION: MiR-483 Promotes Colorectal Cancer Cell Biological Progression by Directly Targeting NDRG2 through Regulation of the PI3K/AKT Signaling Pathway and Epithelial-to-Mesenchymal Transition (Retraction of Vol 2022, art no 4574027, 2022)
Journal Healthcare Engn, Journal of Healthcare
JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
[29] RETRACTION: Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer (Retraction of Vol 12, art no 81, 2021)
Zhao, Mengyang
Xu, Ping
Liu, Zhen
Zhen, Yan
Chen, Yiyu
Liu, Yiyi
Fu, Qiaofen
Deng, Xiaojie
Liang, Zixi
Li, Yonghao
Lin, Xian
Fang, Weiyi
CELL DEATH & DISEASE, 2021, 12 (07)
[30] RETRACTION: Extracellular vesicle-encapsulated microRNA-425-derived from drug-resistant cells promotes non-small-cell lung cancer progression through DAPK1-medicated PI3K/AKT pathway (Retraction of Vol 236, Pg 3808, 2021)
Guo, Zhihua
Ye, Huangyang
Zheng, Xiaobin
Yin, Weiqiang
He, Jianxing
JOURNAL OF CELLULAR PHYSIOLOGY, 2022,